Our History

Founded in 2017, Olympic Ophthalmics is a medical device company focused on developing novel therapies to treat ophthalmic and other disease categories with high unmet needs. Our leadership brings extensive experience in neuromodulation, energy-based technology, and medical device commercialization.

Our first product, iTEAR^®100, was cleared by the FDA in 2020. A second-generation device was cleared in 2022. iTEAR^®100 is a neurostimulation device that increases tear production through gentle stimulation of the external nasal nerve. It is drug-free and drop-free, and its safety and efficacy were established in clinical trials.

iTEAR^®100 is not currently available. The company is working to restore patient access. Join our notification list to be contacted when the device returns.